Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horatiu Olteanu

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Leukemia|March 25, 2023
Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesisTerra Lasho, Christy Finke, Michael Timm, et al.
Leukemia Research|March 2, 2022
Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMMLZhuoer Xie, Gina Campestri, Terra Lasho, et al.
Rheumatology (Oxford, England)|October 11, 2024
Vasculitis associated with VEXAS syndromeMegan Sullivan, Carolyn Mead-Harvey, Julio C Sartori-Valinotti, et al.
Blood Cancer Journal|February 29, 2024
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometryPedro Horna, Matthew J Weybright, Mathieu Ferrari, et al.
Archives of Pathology & Laboratory Medicine|September 30, 2023
PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry CommitteeDavid M Dorfman, Katherine A Devitt, Wei Cui, et al.
American Journal of Clinical Pathology|February 27, 2024
Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patientsHoratiu Olteanu, Mrinal Patnaik, Matthew J Koster, et al.
Cancer Genetics|November 15, 2021
Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusionsAlaa Koleilat, Patrick W McGarrah, Horatiu Olteanu, et al.
Annals of Diagnostic Pathology|March 28, 2022
Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literatureMarie-France Gagnon, James B Smadbeck, George Vasmatzis, et al.
Annals of Diagnostic Pathology|May 15, 2021
Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphomaAdam J Guenzel, James B Smadbeck, Crystal L Golden, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2018
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment RegimenNirav N Shah, Aniko Szabo, Raya Saba, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Leukemia|March 25, 2023
Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesisTerra Lasho, Christy Finke, Michael Timm, et al.
Leukemia Research|March 2, 2022
Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMMLZhuoer Xie, Gina Campestri, Terra Lasho, et al.
Rheumatology (Oxford, England)|October 11, 2024
Vasculitis associated with VEXAS syndromeMegan Sullivan, Carolyn Mead-Harvey, Julio C Sartori-Valinotti, et al.
Blood Cancer Journal|February 29, 2024
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometryPedro Horna, Matthew J Weybright, Mathieu Ferrari, et al.
Archives of Pathology & Laboratory Medicine|September 30, 2023
PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry CommitteeDavid M Dorfman, Katherine A Devitt, Wei Cui, et al.
American Journal of Clinical Pathology|February 27, 2024
Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patientsHoratiu Olteanu, Mrinal Patnaik, Matthew J Koster, et al.
Cancer Genetics|November 15, 2021
Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusionsAlaa Koleilat, Patrick W McGarrah, Horatiu Olteanu, et al.
Annals of Diagnostic Pathology|March 28, 2022
Identification of EWSR1 rearrangements in patients with immature hematopoietic neoplasms: A case series and review of literatureMarie-France Gagnon, James B Smadbeck, George Vasmatzis, et al.
Annals of Diagnostic Pathology|May 15, 2021
Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphomaAdam J Guenzel, James B Smadbeck, Crystal L Golden, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2018
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment RegimenNirav N Shah, Aniko Szabo, Raya Saba, et al.
Pageof 12